Lomustine in Dogs

Lomustine, also called CCNU, is an oral chemotherapy drug your vet may use for certain canine cancers. In dogs, it is commonly discussed for lymphoma, mast cell tumors, histiocytic sarcoma, and some tumors involving the brain or spinal cord. Veterinary use is generally extra-label, which means the drug is approved for people but prescribed legally in animals when your vet believes it fits the case.

This medication is not a routine take-home pill like an antibiotic. It is a hazardous chemotherapy drug that needs careful handling, careful scheduling, and repeat lab monitoring. Many dogs tolerate treatment reasonably well, but side effects can be delayed and sometimes serious, especially low blood cell counts and liver injury. That is why lomustine is often managed by your vet with oncology input, even when the capsule is given at home.

Lomustine can be part of a larger cancer plan rather than a stand-alone answer. Depending on the diagnosis, your vet may pair it with surgery, radiation therapy, prednisone, anti-nausea medication, liver-support supplements, or other chemotherapy drugs. The goal may be tumor control, symptom relief, longer remission, or a balance between quality of life and treatment intensity.

For pet parents, the biggest practical points are safety, monitoring, and expectations. You will usually need scheduled bloodwork before and after doses, and your vet may delay or lower future doses if side effects appear. If your dog develops vomiting, bruising, fever, yellowing of the eyes or gums, or unusual tiredness, contact your vet promptly.

Lomustine is an alkylating chemotherapy drug. In simple terms, it damages genetic material inside cells and interferes with the way cancer cells copy themselves. Cancer cells divide more actively than many normal cells, so they are often more vulnerable to this kind of damage. That said, healthy fast-dividing cells can also be affected, which is why side effects happen.

One reason lomustine is useful in some cancer cases is that it is lipophilic, meaning it dissolves well in fat and can cross into the central nervous system more effectively than many other drugs. That makes it a medication your vet may consider for some brain or spinal cord tumors. It is also used in cancers such as mast cell tumors, lymphoma, and histiocytic sarcoma, where it may be chosen because of prior response patterns, tumor type, or the need for an oral at-home option.

Lomustine does not work instantly. The anti-cancer effect unfolds over days to weeks, while some toxic effects can also be delayed. Blood cell suppression often shows up about a week after treatment and may continue for longer depending on the dog and the protocol. Because of that timing, your vet usually schedules recheck bloodwork after each dose rather than relying only on how your dog looks at home.

Response to lomustine varies widely. Some dogs have meaningful tumor shrinkage or disease control, while others have only a short response or need a different plan. Your vet uses the diagnosis, stage, prior treatments, bloodwork trends, and your goals for care to decide whether conservative, standard, or advanced treatment planning makes the most sense.

Common side effects of lomustine in dogs include decreased appetite, vomiting, diarrhea, mouth sores, lethargy, and weakness. Some dogs also develop hair thinning, eye irritation, or delayed recovery after treatment. Mild stomach upset may pass with supportive care, but any persistent vomiting, diarrhea, or refusal to eat should be reported to your vet.

The more important risks are delayed bone marrow suppression and liver toxicity. Bone marrow suppression can lower white blood cells, platelets, and sometimes red blood cells. That can leave a dog more vulnerable to infection, bruising, bleeding, and fatigue. In some dogs, the white blood cell drop appears around 7 days after treatment, but the risk window can extend longer, so your vet will usually recommend timed blood tests after each dose.

Liver injury is one of the best-known concerns with lomustine. Merck notes that serious liver injury has been estimated in up to 6% of dogs receiving lomustine. Pet parents should watch for yellowing of the eyes, gums, or skin, dark urine, severe tiredness, or a sudden decline in appetite. Your vet may recommend liver enzyme monitoring and, in some cases, a liver-support product as part of the treatment plan.

See your vet immediately if your dog develops fever, bruising, bleeding, severe lethargy, trouble breathing, yellow discoloration, or major vomiting or diarrhea after lomustine. These signs can point to infection, low platelets, liver injury, or overdose. Because reactions may worsen with repeated exposure, a dog that handled earlier doses well can still have trouble later in the course.

Lomustine dosing in dogs is highly individualized. Your vet calculates the dose based on your dog’s body size, cancer type, prior chemotherapy history, organ function, and bloodwork results. It is usually given by mouth as a capsule on a strict schedule, often with weeks between doses rather than daily use. Some oncology plans use different schedules, including lower-dose metronomic approaches in select cases, but those decisions depend on the diagnosis and the full treatment plan.

Do not change the dose, split capsules, or give an extra dose if one is missed unless your vet specifically tells you to. VCA notes that lomustine is given by mouth and may be compounded into other forms when needed, while PetMD emphasizes that missed doses should be handled by contacting your vet right away. Because this is a hazardous chemotherapy drug, pet parents should wear gloves when handling capsules and follow their clinic’s instructions for waste cleanup after dosing.

Administration details can vary by clinic. VCA advises giving lomustine with food, while PetMD advises pet parents to ask their vet whether it should be given on an empty stomach. That difference is a good reminder to follow the label and your vet’s exact instructions for your dog rather than general internet advice. Storage should follow the prescription label, and the medication should be kept tightly closed, away from light and moisture, and out of reach of children and pets.

Monitoring is part of dosing, not an optional extra. Your vet will usually recommend bloodwork before treatment and again after treatment to check white blood cells, platelets, liver values, and sometimes kidney values. If results are not where they should be, your vet may delay the next dose, reduce the amount, add supportive medications, or switch to another option.

Lomustine can interact with other medications or treatment choices that increase the risk of low blood counts, infection, or organ stress. The broad concern is additive toxicity. If your dog is already receiving another chemotherapy drug, a targeted cancer drug, steroids, immunosuppressive medication, or anything that can affect the liver or bone marrow, your vet may need to adjust the plan and monitor more closely.

Merck notes that chemotherapy doses may need to be lowered when lomustine is used in combination with multikinase inhibitors. In practice, that means combinations involving targeted cancer drugs may require extra caution. PetMD also warns that giving lomustine with certain medications can create health risks and recommends reviewing all current medications, supplements, and medical conditions with your vet before treatment starts.

Vaccination timing also matters. PetMD advises avoiding lomustine in pets who have recently been vaccinated or are scheduled for vaccination, because chemotherapy can affect immune function. Dogs with liver disease, kidney disease, active infection, bone marrow suppression, or lung problems may also need a different plan or closer monitoring. Pregnancy and nursing are additional concerns, and people who are pregnant should not handle the drug.

The safest approach is to give your vet a complete medication list every time. Include prescription drugs, over-the-counter products, probiotics, herbal supplements, CBD products, flea and tick preventives, and anything new started between visits. Even if a product seems minor, it can matter when your dog is receiving chemotherapy.